Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
This phase II trial demonstrates that enobosarm, a selective AR modulator, shows anti-tumour activity and clinical benefit in women in postmenopause with ER-positive, HER2-negative and AR-positive advanced breast cancer, supporting further investigation of AR activation as a therapeutic strategy
Wegovy costs ~$9,000 monthly
.webp)
resM contains ingredients that may support the natural GLP-1 production in your body through gut microbiome modulation and botanical compounds that enhance GLP-1 signaling
About a quarter of participants (26.9%) were using SGLT2 inhibitors at baseline, and 48.9% used an SGLT2 inhibitor during SOUL
It does not carry a Drug Identification Number (DIN) and cannot be legally sold as a medication or supplement in Canada
Critical component in peptide research protocols requiring precise dosing and contamination prevention
